Skip to main content
. 2024 Feb 16;15:1330021. doi: 10.3389/fimmu.2024.1330021

Figure 1.

Figure 1

The gut-lung axis represents a bidirectional regulatory pathway between the gut microbiome and ARDS. On one hand, ARDS alters the distribution of the gut microbiome and affects the intestinal mucosal barrier through changes in the microbial composition. On the other hand, modulation of the gut microbiome can influence the development and progression of ARDS by further impacting immune functions, cellular functions, and related signaling pathways during ARDS.